Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf* 8
: 09-101
"$ &: " :
& ! : " " ,% , # .
' & & ( ): 14 |
|
(: L03 _ |
|
) : * 8 |
[ |
, $ |
|
" " . ; % & , . ' "$ - % , & , " , $, &
. |
" |
|
|
|
||
: , |
&, |
, |
% " |
, |
||
& . + – |
& , # " – |
|||||
$. $# |
. |
|
||||
$ : |
|
|
|
|
|
|
- " (39-45%), |
|
|
||||
- - " (55-61 %) |
|
|||||
_: " $# |
|
|
|
|||
* : " |
% % |
, |
||||
- |
& . |
|
|
|
|
|
" : 3 |
|
|
|
38-40 !. |
||
|
: ) " |
< $ ; &$,. % $ $ , . G " , , , " . H% " % % " " , & . % " % " # &, . L 8-12 " % " " 2-3 , % " , %$# . " & " . '" % , % . @ " , , , $. ; & . " % % $ & (3-6 ), $ ,3 $# . ' & "$ , $# $ , " , $# .
" & :
1.# (6 )
2.# "
3.[ " & & .
4. |
|
|
5. |
|
, , $ |
6. |
|
?J; |
7.7
8.[
9.B &
10.B
11.3-
12.HbsAg, Anti-HCV.
" & & :
+ : # % %" % % . @ 1-1,5 , % & % % " . ) $
" |
|
|
( , |
||
, |
$, |
) |
2-3 ". |
|
$# |
|
, |
" |
|
|
& . % 3$. " # " &$ . + % " $ " (H_, H'L .), % $ 3 $, , & , " . & $ $, % & , & $# . @ "&& " 5 \ \ & " 10 .
% & . L & " " , & & . J & & - 15-30%.
" & :
1.*@ V 1% 1
2.*; V 1% 1
3.*/ V 250 , 500 , 1000
4.*J V 10% 2
5.* 0,25
6.* V 40 / , 80 /2
7.*B & 150 – 10 \ .
8.*_ 50 , 150 ; / 100
9.*- 1%
10.*$ 5%, 10% 400 , 500 ; 40% 5 , 10
11.*! V ,
12.* " V 2 , 3 , 5 ,
13. |
*? -" V , 1 |
14. |
*B 3 |
15.*; V 5% 1
16.* 10 , 20 ; V 1%, 5% 1
17.*/ V 1 (500 )
18.*G 25 ; V 20 /
19.* & 3% 25 , 40
20.*6 & V 25% 20
21.*+ 20
22.*@ 2 , 5
23.* , " , #$# &
24.*+ , - / / 200
25.* 1:10 000
" & & :
|
,- ! : % |
, |
# . |
/ , & :
1.< .?. « + % % »
2.< .?., & J.6. « »
3.@ !.;., < <., ; M., ? ?. « @ »
4.B M._., @ !.O. « @ »
* – , # (% % ) .
W &, !
: 07-067
"$ &: " :
& ! : % "
' & & ( ): 10
(: K80.2 % " K80 D " & ( ) K81 G
) : G – & , $# % % " , -" .
$ : G " , 3 % , " 3 ( , ). G " , % , % # .
* : " , % " # ,( -" ), % ,% # , % , %$# &
" |
$ & % " , , % " , |
||||
& |
& |
, |
% # |
$# |
|
" " . |
|
|
|
||
" : |
|
|
|
|
|
" |
: % " |
, " |
|
|
|
5 : |
|
1.#
2.# "
3.<
4.?!;
5.?J;
6.# "
7.#
8.!-
12.
13.Rh-
15.7
|
: & 3 " % |
|
, 30 & " ; , |
% , , # % # , % % , & .
" & :
1.# (6 )
2.# "
3.$
5.
6.7
7."
8._ $
9.6
10.'BL
11.HbsAg, Anti-HCV
13.H)B $
14.H)B " , % " , % " %
15.@ & (7G@) )
16.7
17.&$
18.6
19.G
20.7 "
21.< " , " " & %
22.&
" & & :
+ : G 3 ,7 G !; ? &% . . % "& &$ % % .& " . > &, " .
$ 3 & " :
G " & ;
|
% " ; |
|
( 2-3 " ; |
G " ;
< ( ).
> # % " |
" |
$ |
, # |
||||
" 3 . ' |
|
# |
|||||
& |
" . |
|
|
|
|
||
3 |
|
|
|
|
, |
% |
|
" % " . |
|
|
|
|
|
||
3 |
$ " # " |
||||||
% , |
3 & |
& |
|||||
6-8 . |
|
|
|
|
|
|
|
' & " & |
|
|
|||||
1. / & |
500-750 2 & " 10 . |
|
|||||
2. @ & / & . ' 1- & "$ 200 /, |
$# |
||||||
100-200 % . |
|
|
|
||||
% & & |
2- &. |
|
|
|
3. 7 &. - 400-600 , 200-400 % 6 " . " % 7-14 . $ 1 "" 2-3 " .
4.@ " && 400 \ " 10 .
5.& 480-960 2 12 " . " 10 .
6. / &, , |
250-500 2 |
|
|||
. " 10-14 . |
|
|
|||
= ( & |
) |
|
|||
1. / |
|
10 3-4 & 100-200 3-4 &, |
|||
|
1 |
. 3 &. % & & — 2- &. |
|
||
2. G |
2-3 |
. 3 & |
2 . 3-4 & |
|
|
, $# . |
|
|
|||
% & & 3-4 &. |
|
|
3., " 3- & 1-2 " 2-3 &.
' % " 3 && % .
4.? , 1,5-2 " .
" & :
1. *; V 1% 1
2.*/ 250 , 500
3.*+ 0,9% - 400
4.*$ 5%, 10% 400 , 500 ; 40% 5 , 10
5.*B & 150 – 10 \ .
6.*@ V 1% 1
7.400 ,
8.*? 5% - 100 ,
9.*6 - 5 / 100
10.*@ . 35000-400
11.*@ V 40 /2
12.*; V 5% 1
13.* 10 , 20 ; V 1%, 5% 1
14.* 10
15.*? 50 , 100 , 500 ; V 5%, 10%
|
2 , 5 |
16. |
*; 1 5%, 10%, 30% |
|
50% |
17. |
*/ V 1000 |
" & & :
1.* % % 0,1
2.*? & 5%, 10%, 20%
,- ! : % ,
/ , & :
1.Gallstones. NIH Publication No. 05–2897. November 2004;
2.American college of surgeons. Cholecystectomy. Surgical removal of the gallbladder;
3.Parmet S., Writer M.C., Lynm C. Acute Cholecystitis. JAMA, vol 289, No.1, January 1, 2003.
* – , # (% % ) .
<
: 03-028
"$ &: " :
& ! : % " %
' & & ( ): 26
(:
H66 "
H71 G
) : < (<9;)) ( ), $#" " % 2-6 & "$ $ . " " $ " & " , , . G –, $# "3 . $# 3 % & " , " $ " .
* : &
, |
, . |
|
|
|
||
" : |
|
|
|
|
||
|
|
: " – % |
||||
|
, $# " |
, |
||||
" |
|
|
% & %$, |
#$, |
||
$ &$ |
; |
– |
|
|||
|
|
, |
" |
, |
||
|
$# 3 & . |
|
" & :
1."
3.'
4.B #&$
5.? ( , ! 7)
6.; &
7."
8.V
" & & :
+ : >& & 3% . % " & &50 %. H .
? & : 1500 , +1875 , 500 , 1000 , 500 . @ " && 400 \ " 21 .
+ '! – 1200 , 100 & .
: + " 3 , % , ,